Sunzen Biotech

SUNZEN

MYQ0148OO005

Food Processing

End-of-day quote BURSA MALAYSIA Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
0.345 ^MYR	-1.43%		-5.48%	+15.00%

05-06	Sunzen Biotech Berhad executed a non-binding Term Sheet to acquire 70% stake in Eye Nation Medical Sdn.Bhd from Mr. Lee Peng Hwa and Madam Lay Lee Chin for MYR 6.37 million	CI
05-03	Sunzen Biotech Shelves Plans of MYR4.3 Million Stake Acquisition in Farmer International	MT

Sunzen Biotech Berhad Reports Earnings Results for the Full Year Ended December 31, 2023

February 29, 2024 at 12:42 pm

Sunzen Biotech Berhad reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was MYR 98.13 million. Net income was MYR 6.8 million.

Basic earnings per share was MYR 0.0096. Diluted earnings per share was MYR 0.0089.

Latest news about Sunzen Biotech

Sunzen Biotech Berhad executed a non-binding Term Sheet to acquire 70% stake in Eye Nation Medical Sdn.Bhd from Mr. Lee Peng Hwa and Madam Lay Lee Chin for MYR 6.37 million	05-05	CI
Sunzen Biotech Shelves Plans of MYR4.3 Million Stake Acquisition in Farmer International	05-03	MT
Sunzen Biotech to End Operations of Loss-Making Animal Health Unit	04-09	MT
Sunzen Biotech Berhad Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
Sunzen Biotech Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-29	CI
Sunzen Biotech Buys MYR4.3 Million Stake in Farmer International	01-25	MT
Sunzen Biotech Berhad agreed to acquire additional 30% stake in Ecolite Biotech Manufacturing Sdn Bhd from group of sellers for MYR 18.2 million.	12-19	CI
Sunzen Biotech Berhad Announces Change of Address	12-18	CI
Sunzen Biotech Berhad Announces Appointment of Puan Aida Lim Binti Abdullah as Independent and Non Executive Member of Audit Committee	12-01	CI
Sunzen Biotech Berhad Announces Appointment of Aida Lim Binti Abdullah as Independent and Non Executive Member of Nomination Committee	12-01	CI
Sunzen Biotech Berhad Announces Appointment of Puan Aida Lim Binti Abdullah as Independent and Non Executive Independent Director	12-01	CI
Sunzen Biotech Berhad Announces Appointment of Aida Lim Binti Abdullah as Independent and Non Executive Member of Remuneration Committee	12-01	CI
Sunzen Biotech Berhad Announces Change in Financial Year End	11-29	CI
Sunzen Biotech Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-29	CI
Sunzen Biotech Berhad Announces Resignation of Zeenath Begum Binti Mohamed Mastan as Joint Company Secretary	11-29	CI
Sunzen Biotech Berhad Appoints Cheng Weng Soon as Joint Company Secretary	11-29	CI
Sunzen Biotech Berhad Appoints Lee Yew Weng as Non Independent and Non Executive Member of Nomination Committee	11-01	CI
Sunzen Biotech Berhad Announces Redesignation of Khoo Kien Hoe from Independent and Non Executive Member of Nomination Committee to Independent and Non Executive Chairman of Nomination Committee	11-01	CI
Sunzen Biotech Berhad Appoints Lee Yew Weng as Non Independent and Non Executive Member of Audit Committee	11-01	CI
Sunzen Biotech Berhad Announces Appointment of Lee Yew Weng as Non Independent and Non Executive Member of Remuneration Committee	11-01	CI
Sunzen Biotech Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	30/08/23	CI
Sunzen Biotech Berhad Announces Resignation of FONG CHAN SENG as Independent and Non Executive Member of Audit Committee	04/08/23	CI
Sunzen Biotech Berhad Announces the Resignation of Dr. Fong Chan Seng as Independent and Non Executive Director, Member of Remuneration Committee, Chairman of Nomination Committee	04/08/23	CI
Sunzen Biotech Berhad Reports Earnings Results for the First Quarter Ended March 31, 2023	26/05/23	CI
Sunzen Biotech Berhad Announces Resignation of Tan Sri Haji Musa Bin Tan Sri Haji Hassan as Independent and Non Executive Chairman	26/05/23	CI

Sunzen Biotech Berhad is a Malaysia-based company, which is principally engaged in the businesses of biotechnology research and development, manufacturing and marketing of animal feed supplement products and investment holding. The Company operates through four segments: Manufacturing and trading of animal health products, Trading and processing of crude palm oil and related products, Traditional Chinese medicines and herbal health foods and beverages, and Loan financing. Its products include bird's nest, The Joy of Life collagen drink, Pu Yao Jing tonic, essence of chicken, essence of fish, Pi Pa Gao cough syrup, Bai Foong Wan, food supplements, dried herbs and more. The products are widely distributed to all consumers through retail concept stores in Malaysia as well in Ecolite store online shop. Its subsidiaries include Sunzen Corporation Sdn. Bhd., Sunzen International Sdn. Bhd., Finsource Credit (M) Sdn. Bhd., and Sunzen Lifesciences Sdn. Bhd among others.

Sector

Food Processing

Calendar

23/05/2024 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Food Processing

	1st Jan change	Capi.
SUNZEN BIOTECH	+15.00%	52.72M
NESTLÉ S.A.	-0.91%	276B
MONDELEZ INTERNATIONAL, INC.	-1.73%	96.47B
KRAFT HEINZ	-2.65%	43.8B
THE HERSHEY COMPANY	+11.05%	42.1B
DANONE	+2.15%	41.76B
GENERAL MILLS, INC.	+9.36%	40.31B
ARCHER-DANIELS-MIDLAND COMPANY	-14.68%	30.45B
NESTLÉ INDIA LIMITED	-8.06%	28.49B
ASSOCIATED BRITISH FOODS PLC	+15.34%	25.9B